n/a
Article Publish Status: FREE
Abstract Title:

Bilateral herpes simplex keratitis reactivation after lacrimal gland botulinum toxin injection.

Abstract Source:

Indian J Ophthalmol. 2018 May ;66(5):697-699. PMID: 29676321

Abstract Author(s):

Purvasha Narang, Swati Singh, Vikas Mittal

Article Affiliation:

Purvasha Narang

Abstract:

Botulinum toxin A (BTA) injections into lacrimal gland are being used for refractory epiphora due to intractable lacrimal disorders with success rates reported from 18% to 86%. Most common side effects are transient ptosis and diplopia. We report a case of a 59-year-old female injected with 2.5 units of BTA injection in each lacrimal gland for functional epiphora. The patient had a history of herpes simplex viral keratitis that was quiescent for more than 2 years. After 3 weeks, she developed reactivation of viral keratitis bilaterally, which was successfully managed with antivirals and topical steroids. Reactivation of quiescent herpes simplex keratitis is a possibility after lacrimal gland BTA and caution should be exercised in such cases.

Study Type : Human: Case Report
Additional Links
Problem Substances : Botox : CK(98) : AC(12)

Print Options


Key Research Topics

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.